Brooks, Jennifer

Sr. Manager, Drug Safety and Pharmacovigilance Operations at Halozyme, Inc. - San Diego, California, US

Brooks, Jennifer's Colleagues at Halozyme, Inc.
Miriam Shiotani

Sr. Manager, Quality Assurance

Contact Miriam Shiotani

Cintamani Bridges

Executive Administrator to the CEO

Contact Cintamani Bridges

Patricia Weigand

Senior Front Desk Administrator 1/Senior Administrative Assistant 1

Contact Patricia Weigand

Vince Vilaysane

Sr. Network Systems Admin.

Contact Vince Vilaysane

Donna Callaway

Senior Executive Assistant

Contact Donna Callaway

Eddie Howard

Senior Quality Assurance Specialist, Computer Systems

Contact Eddie Howard

View All Brooks, Jennifer's Colleagues
Brooks, Jennifer's Contact Details
HQ
(858) 794-8889
Location
Company
Halozyme, Inc.
Brooks, Jennifer's Company Details
Halozyme, Inc. logo, Halozyme, Inc. contact details

Halozyme, Inc.

San Diego, California, US • 468 Employees
BioTech/Drugs

Halozyme is a biopharmaceutical company bringing disruptive solutions to significantly improve patient experiences and outcomes for emerging and established therapies. Halozyme advises and supports its biopharmaceutical partners in key aspects of new drug development with the goal of improving patients' lives while helping its partners achieve global commercial success. As the innovators of the ENHANZE® technology, which can reduce hours-long treatments to a matter of minutes, Halozyme's commercially-validated solution has positively impacted more than 400,000 patient lives via five commercialized products across more than 100 global markets. Halozyme and its world-class partners are currently advancing multiple therapeutic programs intended to deliver innovative therapies, with the potential to improve the lives of patients around the globe. Halozyme's proprietary enzyme rHuPH20 forms the basis of the ENHANZE® technology and is used to facilitate the delivery of injected drugs and fluids, potentially reducing the treatment burden of other drugs to patients. Halozyme has licensed its ENHANZE® technology to leading pharmaceutical and biotechnology companies including Roche, Baxalta, Pfizer, Janssen, AbbVie, Lilly, Bristol-Myers Squibb, Alexion and argenx. Halozyme derives revenues from these collaborations in the form of milestones and royalties as the company's partners make progress developing and commercializing their products being developed with ENHANZE®. We are a diverse team, who are committed to bringing therapies and results to patients. It's not enough to be qualified and experienced at what you do, we are looking for people who believe in our mission and match our values. We are building a company where people can pursue their career goals in a supportive and collaborative team environment. Visit www.halozyme.com/careers for more details. We are Halozyme.

Biopharmaceuticals
Details about Halozyme, Inc.
Frequently Asked Questions about Brooks, Jennifer
Brooks, Jennifer currently works for Halozyme, Inc..
Brooks, Jennifer's role at Halozyme, Inc. is Sr. Manager, Drug Safety and Pharmacovigilance Operations.
Brooks, Jennifer's email address is ***@halozyme.com. To view Brooks, Jennifer's full email address, please signup to ConnectPlex.
Brooks, Jennifer works in the BioTech/Drugs industry.
Brooks, Jennifer's colleagues at Halozyme, Inc. are Miriam Shiotani, Jordan Lambrecht, Cintamani Bridges, Patricia Weigand, Vince Vilaysane, Donna Callaway, Eddie Howard and others.
Brooks, Jennifer's phone number is (858) 794-8889
See more information about Brooks, Jennifer